ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes
Presenter:
Advertisement
Sign In
New at TCTMD? Register today!
Forgot Your Password?
Enter the email you used to register to reset your password.
Search TCTMD
cme